Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults
Sanjana Mahapatra, Emily M. Mace, Charles G. Minard, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0181134-e0181134
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale André, Caroline Denis, Caroline Soulas, et al.
Cell (2018) Vol. 175, Iss. 7, pp. 1731-1743.e13
Open Access | Times Cited: 1003
Emerging insights into human health and NK cell biology from the study of NK cell deficiencies
Emily M. Mace, Jordan S. Orange
Immunological Reviews (2018) Vol. 287, Iss. 1, pp. 202-225
Open Access | Times Cited: 144
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Antonio Valeri, Almudena García-Ortiz, Eva Castellano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 59
Implications of NKG2A in immunity and immune-mediated diseases
Xiaotong Wang, Huabao Xiong, Zhaochen Ning
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies
Kirk R. Schultz, Amina Kariminia, Bernard Ng, et al.
Blood (2020) Vol. 135, Iss. 15, pp. 1287-1298
Open Access | Times Cited: 53
CD56 regulates human NK cell cytotoxicity through Pyk2
Justin T. Gunesch, Amera L. Dixon, Tasneem Ebrahim, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 53
Human CD8+ T-Cell Populations That Express Natural Killer Receptors
June‐Young Koh, Dong-Uk Kim, Bae-Hyeon Moon, et al.
Immune Network (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Distinct CD16a features on human NK cells observed by flow cytometry correlate with increased ADCC
María C. Rodríguez, Zainab Hakeem, A. Davis, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Neutrophils in community-acquired pneumonia: parallels in dysfunction at the extremes of age
Frances Grudzinska, Malcolm Brodlie, Barnaby R. Scholefield, et al.
Thorax (2019) Vol. 75, Iss. 2, pp. 164-171
Open Access | Times Cited: 53
Genome-wide analyses and functional profiling of human NK cell lines
Justin T. Gunesch, Laura S. Angelo, Sanjana Mahapatra, et al.
Molecular Immunology (2018) Vol. 115, pp. 64-75
Open Access | Times Cited: 51
NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis
Cinzia Fionda, Gianluca Scarno, Helena Stabile, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7859-7859
Open Access | Times Cited: 27
Dual functional nanoparticles efficiently across the blood–brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis
Zheng Gen Jin, Lianhua Piao, Guangchao Sun, et al.
Journal of drug targeting (2020) Vol. 29, Iss. 3, pp. 323-335
Closed Access | Times Cited: 38
Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells
Timo Burster, Fabian Gärtner, Christiane Bulach, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 236-236
Open Access | Times Cited: 28
Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
Dapeng Li, Simon Brackenridge, Lucy C. Walters, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 20
Mechanistic Understanding of EBV+ Lymphoproliferative Disease Development After Transplantation
Philippe L. Furlano, Georg A. Böhmig, Elisabeth Puchhammer‐Stöckl, et al.
Transplantation (2024) Vol. 108, Iss. 9, pp. 1867-1881
Closed Access | Times Cited: 4
Pandemic-Driven Shifts in Epstein-Barr Virus (EBV) Epidemiology: Single Center Study
María Eugenia Amarillo, Karen Lindl, Mercedes García Lombardi, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 375-375
Open Access
Functional T cell response to COVID-19 vaccination with or without natural infection with SARS-CoV-2 in adults and children
Evana Akhtar, Rakib Ullah Kuddusi, Md. Eman Talukder, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Novel Heterozygous Mutation in NFKB2 Is Associated With Early Onset CVID and a Functional Defect in NK Cells Complicated by Disseminated CMV Infection and Severe Nephrotic Syndrome
Alejandra Aird, Macarena Lagos, Alexander Vargas‐Hernández, et al.
Frontiers in Pediatrics (2019) Vol. 7
Open Access | Times Cited: 27
Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function
Alexander Vargas‐Hernández, Agnieszka Witalisz‐Siepracka, Michaela Prchal‐Murphy, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 145, Iss. 1, pp. 345-357.e9
Open Access | Times Cited: 27
A critical threshold of MCM10 is required to maintain genome stability during differentiation of induced pluripotent stem cells into natural killer cells
Megan Schmit, Ryan M. Baxley, Liangjun Wang, et al.
Open Biology (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Natural Killer Cell Function Tests by Flowcytometry-Based Cytotoxicity and IFN-γ Production for the Diagnosis of Adult Hemophagocytic Lymphohistiocytosis
Hyeyoung Lee, Hoon Seok Kim, Jong‐Mi Lee, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5413-5413
Open Access | Times Cited: 23
Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
Martín Villalba, Catherine Alexia, Anais Bellin-Robert, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 23
NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes
Laia Gómez-Muñoz, David Perna‐Barrull, Adrian Villalba, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 20
Role of Cytokines and Growth Factors in the Manufacturing of iPSC-Derived Allogeneic Cell Therapy Products
Chen‐Yuan Kao, Jason A. Mills, Carl J. Burke, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 677-677
Open Access | Times Cited: 7
β-Actin G342D as a Cause of NK Cell Deficiency Impairing Lytic Synapse Termination
Abigail E. Reed, Jackeline Peraza, Frederique van den Haak, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 6, pp. 962-973
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top